• 1 January 1993
    • journal article
    • Vol. 45  (1) , 21-2
Abstract
Flu immunisation programmes have been offered by many organisations this year and companies will be expecting to see the dividend of reduced absenteeism. But are nonselective vaccinations worth the expense? Helen Kogan weighs up the arguments.